The Coronavirus Outbreak Is Now a Public Health Emergency of International Concern. Here ’s What That Means
The World Health Organization (WHO) took the rare step Thursday of declaring a novel coronavirus outbreak that originated in Wuhan, China a public health emergency of international concern (PHEIC). But what does that actually mean? The WHO defines a PHEIC as an “extraordinary event” that “constitute[s] a public health risk to other States through the international spread of disease” and “potentially require[s] a coordinated international response.” Since that framework was defined in 2005—two years after another coronavirus, severe acute respiratory syndrome (SARS), spread through China—it has been used only six times: for outbreaks of “swine flu” in 2009, polio in 2014, Ebola in 2014, Zika virus in 2016, Ebola in 2019 and, now, coronavirus in 2020. A PHEIC is meant to mobilize international response to an outbreak. It’s an opportunity for the WHO, with guidance from its International Health Regulations Emergency Committee, to implement “non-binding but practically &politically significant measures that can address travel, trade, quarantine, screening, treatment. WHO can also set global standards of practice,” the organization tweeted. What does Public Health Emergency of Intl Concern means?WHO issues temporary recommendations. These are non-binding but practically &politically significant measures that can address travel, trade, quarantine, screening, treatment. WHO can also set global s...
Publication date: Available online 3 June 2020Source: Life SciencesAuthor(s): Nehla Banu, Sandeep Surendra Panikar, Lizbeth Riera Leal, Annie Riera Leal
Publication date: Available online 2 June 2020Source: Life SciencesAuthor(s): Fereshteh Yazdanpanah, Michael R. Hamblin, Nima Rezaei
Publication date: Available online 1 June 2020Source: Life SciencesAuthor(s): Abhjieet Pandey, Ajinkya Nitin Nikam, Ajjappla Basavraj Shreya, Sadhana P. Mutalik, Divya Gopalan, Sanjay Kulkarni, Bharath Singh Padya, Gasper Fernandes, Srinivas Mutalik, Ruth Prassl
Publication date: 1 September 2020Source: Life Sciences, Volume 256Author(s): Fedor Simko, Russel J. Reiter
Authors: Frost DW, Shah R, Melvin L, Galán de Juana M, MacMillan TE, Abdelhalim T, Lai A, Rawal S, Cavalcanti RB PMID: 32493744 [PubMed - as supplied by publisher]
Authors: Boodman C, Lagacé-Wiens P, Bullard J PMID: 32493742 [PubMed - as supplied by publisher]
Authors: Mishra S, Kwong JC, Chan AK, Baral SD PMID: 32493741 [PubMed - as supplied by publisher]
Authors: Liu W, Zhou P, Chen K, Ye Z, Liu F, Li X, He N, Wu Z, Zhang Q, Gong X, Tang Q, Du X, Ying Y, Xu X, Zhang Y, Liu J, Li Y, Shen N, Couban RJ, Ibrahim QI, Guyatt G, Zhai S Abstract BACKGROUND: Antiviral medications are being given empirically to some patients with coronavirus disease 2019 (COVID-19). To support the development of a COVID-19 management guideline, we conducted a systematic review that addressed the benefits and harms of 7 antiviral treatments for COVID-19. METHODS: We searched MEDLINE, Embase, Cochrane Central Register of Controlled Trials (CENTRAL), PubMed and 3 Chinese databases (CNKI, WA...
Publication date: Available online 4 June 2020Source: Protein Expression and PurificationAuthor(s): Dominic Esposito, Jennifer Mehalko, Matthew Drew, Kelly Snead, Vanessa Wall, Troy Taylor, Peter Frank, John-Paul Denson, Min Hong, Gulcin Gulten, Kaitlyn Sadtler, Simon Messing, William Gillette
Publication date: Available online 5 June 2020Source: Pesticide Biochemistry and PhysiologyAuthor(s): Yun-Xia Zhao, Jing-Mei Huang, Huan Ni, Di Guo, Feng-Xia Yang, Xin Wang, Shun-Fan Wu, Cong-Fen Gao